We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Minimally Invasive Catheter-Based Technology Treats Pulmonary Hypertension

By HospiMedica International staff writers
Posted on 06 Jun 2023
Print article
Image: The novel intravascular, catheter-based technology is designed to treat pulmonary hypertension (Photo courtesy of Freepik)
Image: The novel intravascular, catheter-based technology is designed to treat pulmonary hypertension (Photo courtesy of Freepik)

Pulmonary hypertension, a deadly condition impacting roughly 500,000 patients annually across the world, is currently categorized as a rare disease. As it stands, available treatment options are restricted, and no cure has been identified. Now, a highly disruptive technology aims at reducing pulmonary vascular resistance and improving cardiovascular hemodynamics in patients with thickened and narrowed pulmonary arteries.

Gradient Denervation Technologies (Paris, France) is developing a device-based minimally invasive solution to treat pulmonary hypertension. The company’s novel intravascular, catheter-based technology aims is designed to restore the benefits of a healthy, elastic pulmonary artery. This, in turn, can reduce cardiac workload, improve blood flow, and restore pulmonary pressure to normal levels. Gradient's technology works by reducing pulmonary vascular resistance and improving cardiovascular hemodynamics through the downregulation of the sympathetic nervous system’s input into the pulmonary vascular tree.

Increased pulmonary vascular resistance contributes to a substantial rise in mortality and hospitalization risk in heart failure patients. Given the lack of approved drug or device therapies for this subset of pulmonary hypertension patients, Gradient's technology can significantly impact patient care. The company provides a device-based, minimally invasive solution for treating pulmonary hypertension, offering the healthcare sector a tool that produces consistent and lasting results. Following the successful completion of the first procedure in its first-in-human clinical study for the pulmonary hypertension device, the company will target FDA approval and initiate an IDE Early Feasibility Study in the US later this year.

Related Links:
Gradient Denervation Technologies

Platinum Supplier
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Supplier
Conductive Gel
Tensive
New
Digital Single Channel ECG
ECG-11DII
New
Gold Supplier
Calibration Syringe
Calibration Syringes

Print article
Radcal

Channels

Surgical Techniques

view channel
Image: The ARC-IM Stimulator with brain-computer interface restores arm, hand, and finger function after spinal cord injury (Photo courtesy of ONWARD Medical)

First-in-Human Implant of Thought-Driven Movement Device to Treat Spinal Cord Injury

In order to walk, signals from the brain are sent to neurons in the lumbosacral part of the spinal cord. When a spinal cord injury occurs, it cuts off this essential communication between the brain and... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The broad-spectrum POC coagulometer is well-suited for emergency room and emergency vehicle use (Photo courtesy of Perosphere)

Novel POC Coagulometer with Lab-Like Precision to Revolutionize Coagulation Testing

In emergency settings, when patients arrive with a bleed or require urgent surgery, doctors rely solely on clinical judgment to determine if a patient is adequately anticoagulated for reversal treatment.... Read more

Business

view channel
Image: The global surgical lights market is expected to grow by close to USD 0.50 billion from 2022 to 2027 (Photo courtesy of Freepik)

Global Surgical Lights Market Driven by Increasing Number of Procedures

The global surgical lights market is set to witness high growth, largely due to the increasing incidence of chronic illnesses, a surge in demand for cosmetic and plastic surgeries, and untapped opportunities... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.